Heart failure: advanced development in genetics and epigenetics

Area of Science:

• Cardiology
• Genetics
• Epigenetics

Background:

• Heart failure (HF) is a complex syndrome resulting from impaired cardiac function.
• Genetic mutations in cardiomyopathies are linked to various HF pathologies.
• Epigenetic mechanisms, including chromatin remodeling and DNA methylation, are implicated in HF.

Purpose of the Study:

• To review genetic mutations associated with cardiomyopathy.
• To explore the role of epigenetic mechanisms in heart failure.
• To highlight the potential of genetic screening for individualized HF therapies.

Main Methods:

• Literature review of genetic mutations in familial dilated cardiomyopathy, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.
• Overview of epigenetic mechanisms: ATP-dependent chromatin remodeling, DNA methylation, histone modification, and RNA-based mechanisms.
• Focus on microRNA's role in heart failure research.

Main Results:

• Specific genetic mutations contribute to diverse cardiomyopathy pathologies.
• Epigenetic modifications are crucial regulatory pathways in HF.
• MicroRNAs are significant factors in the pathophysiology of HF.

Conclusions:

• Genetic screening offers a pathway for personalized HF treatment and monitoring.
• Epigenetic factors, particularly microRNAs, are critical targets for future HF research.
• Integrating genetic and epigenetic insights is vital for advancing heart failure management.